微生理学工程血管-瘤模型研究免疫细胞的血管运输动力学
Yuwen Zhao1, Yue Wu1, Khayrul Islam2
1Department of Bioengineering, Lehigh University, Bethlehem, Pennsylvania 18015, United States.
ACS applied materials & interfaces
|April 23, 2024
概括
本研究提出了一个3D微流体模型,可视化T细胞的运输和瘤中的相互作用. 该平台评估了内皮质葡萄糖和PD-1抑制如何影响癌症免疫疗法的有效性.
科学领域:
- 生物医学工程 生物医学工程
- 癌症研究 癌症研究
- 免疫学 免疫学 免疫学
背景情况:
- 癌症免疫疗法显示出希望,但缺乏体内观察方法.
- 了解瘤中的免疫细胞运输对于有效治疗至关重要.
研究的目的:
- 开发和使用3D微流体血管瘤模型来研究T细胞运输和免疫疗法.
- 为了研究内皮质葡萄糖在T细胞-内皮相互作用中的作用.
- 评估PD-1免疫检查点抑制对T细胞介导瘤杀伤的影响.
主要方法:
- 开发一个3D微流体血管支持瘤模型,具有内皮膜光和血管网络.
- 在体外监测T细胞通过血管网络的运输和与瘤球体的相互作用.
- 评估内皮糖对T细胞运输和相互作用的影响.
- 评估编程细胞死亡蛋白1 (PD-1) 免疫检查点抑制对激活的T细胞和瘤杀伤的影响.
主要成果:
- 证明了内皮质葡萄糖对T细胞运输和内皮质免疫相互作用的影响.
- 量化了PD-1免疫检查点抑制对T细胞介导的瘤杀死后血管运输的影响.
- 在工程模型中成功表示和监测T细胞的运输和相互作用.
结论:
- 这种3D血管-瘤模型作为一种微生理学工程平台,用于研究T细胞在癌症免疫治疗中的血管运输.
- 这一创新的平台可以探索瘤诱导的免疫反应,并帮助临床前评估免疫疗法疗效.
相关概念视频
Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models
Physiological pharmacokinetic models, often called flow-limited or perfusion models, typically assume a swift drug distribution between tissue and venous blood, creating a rapid drug equilibrium. This premise is based on the idea that drug diffusion is extremely fast, and the cell membrane presents no barrier to drug permeation. In this scenario, where no drug binding occurs, the drug concentration in the tissue equals that of the venous blood leaving the tissue. This greatly simplifies the...
Applications of Integration to Find Blood Flow
Blood flow through a cylindrical blood vessel can be mathematically described using the principles of laminar flow, a regime in which fluid moves smoothly in parallel layers. In this model, the velocity of the blood is not uniform across the cross-section of the vessel; rather, it varies with the radial distance from the center. The maximum velocity occurs along the central axis, decreasing progressively toward the vessel walls, where it reaches zero due to viscous drag.Approximating Blood...


